| 发明名称 |
USE OF GLU-TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES |
| 摘要 |
Use of glu-tubulin as a biomarker for predicting the response to a compound, preferably resistance of a disease such as cancer in a subject to said compound, wherein the compound is a furazanobenzimidazole compound of general formula (I). |
| 申请公布号 |
EP2666014(B1) |
申请公布日期 |
2016.10.05 |
| 申请号 |
EP20120700494 |
申请日期 |
2012.01.19 |
| 申请人 |
BASILEA PHARMACEUTICA AG |
发明人 |
LANE, HEIDI ALEXANDRA;BACHMANN, FELIX |
| 分类号 |
G01N33/68;A61K31/4245;G01N33/50 |
主分类号 |
G01N33/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
